Company Analysis Neogen Corporation
1. Summary
Advantages
- The stock's return over the last year (-28.85%) is higher than the sector average (-37.33%).
Disadvantages
- Price (12.83 $) is higher than fair price (0.3015 $)
- Dividends (0%) are below the sector average (0.5399%).
- Current debt level 19.92% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-0.3001%) is lower than the sector average (ROE=9.39%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Neogen Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.8% | -1.7% | -3.7% |
| 90 days | -18.4% | -40.1% | 1.4% |
| 1 year | -28.8% | -37.3% | 20.1% |
NEOG vs Sector: Neogen Corporation has outperformed the "Healthcare" sector by 8.48% over the past year.
NEOG vs Market: Neogen Corporation has significantly underperformed the market by -48.96% over the past year.
Stable price: NEOG is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: NEOG with weekly volatility of -0.5547% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (12.83 $) is higher than the fair price (0.3015 $).
Price is higher than fair: The current price (12.83 $) is 97.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (59.66) is lower than that of the sector as a whole (61.47).
P/E vs Market: The company's P/E (59.66) is higher than that of the market as a whole (51.48).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.913) is lower than that of the sector as a whole (4.79).
P/BV vs Market: The company's P/BV (0.913) is lower than that of the market as a whole (3.44).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.11) is lower than that of the sector as a whole (33.58).
P/S vs Market: The company's P/S indicator (3.11) is lower than that of the market as a whole (10.3).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (19.75) is higher than that of the sector as a whole (-17.26).
EV/Ebitda vs Market: The company's EV/Ebitda (19.75) is lower than that of the market as a whole (29.6).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -23.19% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-23.19%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (11.51%).
5.4. ROE
ROE vs Sector: The company's ROE (-0.3001%) is lower than that of the sector as a whole (9.39%).
ROE vs Market: The company's ROE (-0.3001%) is lower than that of the market as a whole (8.95%).
5.5. ROA
ROA vs Sector: The company's ROA (-0.207%) is lower than that of the sector as a whole (0.1519%).
ROA vs Market: The company's ROA (-0.207%) is lower than that of the market as a whole (6.3%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (5.84%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (5.84%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5399%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 16.01.2025 | Naemura David H. CFO |
Purchase | 11.11 | 164 428 | 14 800 |
| 10.04.2024 | Naemura David H. CFO |
Purchase | 12.51 | 156 375 | 12 500 |
| 11.10.2022 | Quinlan Steven J. VP & CFO |
Purchase | 11.63 | 58 150 | 5 000 |
| 28.09.2022 | ADENT JOHN EDWARD President & CEO |
Purchase | 14.37 | 316 140 | 22 000 |
| 28.09.2022 | Jones Douglas Edward Chief Operating Officer |
Purchase | 14.31 | 100 170 | 7 000 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
